失智症的管理及预防

doi:10.3969/j.issn.1003-9198.2023.06.022

摘要/Abstract

中图分类号:

R 749.1

叶莲, 梁瑞, 张新军. 失智症的管理及预防[J]. 实用老年医学, 2023, 37(6): 626-629.

[1] ARVANITAKIS Z, SHAH R C, BENNETT D A. Diagnosis and management of dementia: review [J]. JAMA, 2019, 322(16): 1589-1599.
[2] LISKO I, KULMALA J, ANNETORP M, et al. How can dementia and disability be prevented in older adults: where are we today and where are we going? [J]. J Intern Med, 2021, 289(6): 807-830.
[3] JIA J, WEI C, CHEN S, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide [J]. Alzheimers Dement, 2018, 14(4): 483-491.
[4] 2022 Alzheimer's disease facts and figures[J]. Alzheimers Dement,2022,18(4):700-789.
[5] SCLAN S G, REISBERG B. Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality [J]. Int Psychogeriatr, 1992, 4 (1): 55-69.
[6] O'BRYANT S E, LACRITZ L H, HALL J, et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database [J]. Arch Neurol, 2010, 67(6): 746-749.
[7] MORRIS J C. The Clinical Dementia Rating (CDR): current version and scoring rules [J]. Neurology, 1993, 43(11): 2412-2414.
[8] OLAZARÁN J, REISBERG B, CLARE L, et al. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy [J]. Dement Geriatr Cogn Disord, 2010, 30(2): 161-178.
[9] SIKKES S A M, TANG Y, JUTTEN R J, et al.Toward a theory-based specification of non-pharmacological treatments inaging and dementia: focused reviews and methodological recommendations [J]. Alzheimers Dement, 2021, 17(2): 255-270.
[10] SCALES K, ZIMMERMAN S, MILLER S J. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia [J]. Gerontologist, 2018, 58(Suppl 1): S88-S102.
[11] BAHAR-FUCHS A, MARTYR A, GOH A M, et al. Cognitive training for people with mild to moderate dementia [J]. Cochrane Database Syst Rev, 2019, 3(3): CD013069.
[12] SARAGIH I D, TONAPA S I, SARAGIH I S, et al.Effects of cognitive stimulation therapy for people with dementia: a systematic review and meta-analysis of randomized controlled studies [J]. Int J Nurs Stud, 2022, 128: 104181.
[13] STRÖHLE A, SCHMIDT D K, SCHULTZ F, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials [J]. Am J Geriatr Psychiatry, 2015, 23(12): 1234-1249.
[14] VAN DER STEEN J T, SMALING H J, VAN DER WOUDEN J C, et al. Music-based therapeutic interventions for people with dementia [J].Cochrane Database Syst Rev, 2018, 7(7): CD003477.
[15] PARK K, LEE S, YANG J, et al.A systematic review and meta-analysis on the effect of reminiscence therapy for people with dementia [J]. Int Psychogeriatr, 2019, 31(11): 1581-1597.
[16] WOODS B, O'PHILBIN L, FARRELL E M, et al. Reminiscence therapy for dementia [J].Cochrane Database Syst Rev, 2018, 3(3): CD001120.
[17] NAM Y, KIM M, CHANG H S, et al.Drug repurposing with network reinforcement [J]. BMC Bioinformatics, 2019, 20(Suppl 13): 383.
[18] DEARDORFF W J, GROSSBERG G T. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease [J]. Drug Des Devel Ther, 2016, 10: 3267-3279.
[19] PARSONS C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem [J]. Ther Adv Drug Saf, 2017, 8(1): 31-46.
[20] ESHETIE T C, NGUYEN T A, GILLAM M H, et al. A narrative review of problems with medicines use in people with dementia [J]. Expert Opin Drug Saf, 2018, 17(8): 825-836.
[21] 田双月, 刘帅, 王志稳. 中重度失智老人居家照护者困扰问题及需求调研 [J]. 中国护理管理, 2019, 19(10): 1502-1507.
[22] PULIDO HERRERA E. Location-based technologies for supporting elderly pedestrian in "getting lost" events [J]. Disabil Rehabil Assist Technol, 2017, 12(4): 315-323.
[23] AGRAWAL A K, GOWDA M, ACHARY U, et al. Approach to management of wandering in dementia: ethical and legal issue [J].Indian J Psychol Med, 2021, 43(5 Suppl): S53-S59.
[24] PECH M, SAUZEON H, YEBDA T, et al.Falls detection and prevention systems in home care for older adults: myth or reality? [J]. JMIR Aging, 2021, 4(4): e29744.
[25] HEGDE N, SAZONOV E. SmartStep: a fully integrated, low-power insole monitor[J]. Electronics, 2014, 3(2):381-397.
[26] STONE E E, SKUBIC M. Evaluation of an inexpensive depth camera for passive in-home fall risk assessment[C]//2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth) and Workshops. Ieee, 2011: 71-77.
[27] LIVINGSTON G, HUNTLEY J, SOMMERLAD A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission [J].Lancet, 2020, 396(10248): 413-446.
[28] CROUS-BOU M, MINGUILLóN C, GRAMUNT N, et al.Alzheimer's disease prevention: from risk factors to early intervention [J]. Alzheimers Res Ther, 2017, 9(1): 71.
[29] LANGA K M. Is the risk of Alzheimer's disease and dementia declining? [J]. Alzheimers Res Ther, 2015, 7(1): 34.
[30] SPERLING R A, AISEN P S, BECKETT L A, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J]. Alzheimers Dement, 2011, 7(3): 280-292.
[31] WEINTRAUB S, CARRILLO M C, FARIAS S T, et al. Measuring cognition and function in the preclinical stage of Alzheimer's disease [J].Alzheimers Dement(NY), 2018, 4: 64-75.
[32] DONOHUE M C, SPERLING R A, SALMON D P, et al.The preclinical Alzheimer cognitive composite: measuring amyloid-related decline [J]. JAMA Neurol, 2014, 71(8): 961-970.
[33] KREMEN W S, BECK A, ELMAN J A, et al. Influence of young adult cognitive ability and additional education on later-life cognition [J]. Proc Natl Acad Sci U S A, 2019, 116(6): 2021-2026.
[34] NORTON S, MATTHEWS F E, BARNES D E, et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data [J]. Lancet Neurol, 2014, 13(8): 788-794.
[35] LARSSON S C, TRAYLOR M, MALIK R, et al. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis [J]. BMJ, 2017, 359: j5375.
[36] BERENDSEN A A M, KANG J H, VAN DE REST O, et al. The dietary approaches to stop hypertension diet, cognitive function, and cognitive decline in American older women [J]. J Am Med Dir Assoc, 2017, 18(5): 427-432.
[37] TANGNEY C C, LI H, WANG Y, et al. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons [J]. Neurology, 2014, 83(16): 1410-1416.

失智症的管理及预防

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	孙丽, 尹卫红, 经俊, 钱夏丽. 亚麻醉剂量艾司氯胺酮对老年脊柱手术病人术后早期认知功能障碍的影响[J]. 实用老年医学, 2024, 38(10): 1039-1043.
[2]	陈昕露, 周艺铭, 韩雪, 顾小萍. 睡眠障碍与老年术后认知功能障碍的双向关联研究进展[J]. 实用老年医学, 2024, 38(5): 433-437.
[3]	蔡文岚, 孙杰. 老年病人术后认知功能障碍的风险因素研究进展[J]. 实用老年医学, 2024, 38(5): 438-437.
[4]	赵倩文, 孙斌, 朱杨子, 顾小萍, 王立伟. 老年病人术后认知功能障碍诊断与干预策略的研究进展[J]. 实用老年医学, 2024, 38(5): 447-437.
[5]	郭金花, 申铁梅, 陈凌, 崔虹, 王小霞, 黄巧, 黄芳, 李芸, 杨满青. 广东省农村老年人认知功能现状及影响因素分析[J]. 实用老年医学, 2024, 38(5): 456-437.
[6]	隗倩, 蔡颖源, 王珊, 谈福云, 陆小伟. 甲状腺功能正常及亚临床甲状腺功能减退的老年人血清促甲状腺激素水平与认知障碍的相关性[J]. 实用老年医学, 2024, 38(5): 486-437.
[7]	张卉, 李霞. 痴呆前心理行为障碍预测阿尔茨海默病的研究进展[J]. 实用老年医学, 2024, 38(5): 512-437.
[8]	焦琳娜, 李宝仪, 王琴, 何建丽. 脑白质病变及大脑皮层厚度与老年轻型卒中后认知功能障碍的相关性研究[J]. 实用老年医学, 2024, 38(3): 287-290.
[9]	董丽华, 李加梅, 郑加平, 雷小晶. 血液生物标志物在阿尔茨海默病早期诊断中的研究进展[J]. 实用老年医学, 2023, 37(12): 1249-1254.
[10]	张伟, 王蓉. 衰老作为神经退行性疾病危险因素的科学现状分析[J]. 实用老年医学, 2023, 37(10): 984-988.
[11]	时建铨, 郑慧芬, 徐畅, 王变荣. 认知障碍简明评价量表与Addenbrooke认知评估量表Ⅲ诊断阿尔茨海默病的准确性比较[J]. 实用老年医学, 2023, 37(10): 1041-1043.
[12]	阎子花, 杜静, 宋竹梅, 张兴梅, 张楠. 痴呆病人病感失认测评工具的研究进展[J]. 实用老年医学, 2023, 37(10): 1059-1063.
[13]	王琳琳, 杨诗怡, 徐俊. 人工智能在阿尔茨海默病中的研究进展[J]. 实用老年医学, 2023, 37(9): 869-872.
[14]	王敏, 郭文军, 汤忠泉, 赵晓敏, 欧婷, 李云涛. 听力障碍与阿尔茨海默病相关性的Meta分析[J]. 实用老年医学, 2023, 37(9): 915-919.
[15]	吕坤, 曹纹平, 王宇航, 赵春生, 曹胜武. 不同麻醉方式在帕金森病病人丘脑底核脑深部电刺激手术中的临床效果[J]. 实用老年医学, 2023, 37(9): 938-942.